Who Paid My Doc
RNS Neurostimulator Kit
Device Epilepsy
PDI 00855547005267
General payments
$1,456,286
Research payments
$4,172,256
Through program year 2025, $1,456,286 in general payments and $4,172,256 in research payments were reported against RNS Neurostimulator Kit (Epilepsy).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $382,505 | 1,164 |
| 2025 | Research | $1,242,614 | 2,511 |
| 2024 | General | $477,376 | 1,828 |
| 2024 | Research | $1,151,982 | 3,152 |
| 2023 | General | $394,161 | 1,206 |
| 2023 | Research | $1,082,882 | 2,372 |
| 2022 | General | $202,244 | 773 |
| 2022 | Research | $694,778 | 1,653 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,971 general · 9,688 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.